Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Goss

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Oncology (Williston Park, N.Y.)|December 12, 1997
Anastrozole: a new selective nonsteroidal aromatase inhibitorP E Goss, L M Tye
The Journal of Biological Chemistry|February 29, 2000
Characterization of a repressor element and a juxtaposed tissue-restricted activator element located on the distal neu gene promoterT C Suen, P E Goss
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Current perspectives on aromatase inhibitors in breast cancerP E Goss, K M Gwyn
The Journal of Biological Chemistry|October 26, 1999
Transcription of BRCA1 is dependent on the formation of a specific protein-DNA complex on the minimal BRCA1 Bi-directional promoterT C Suen, P E Goss
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Evolving perspectives in contralateral breast cancerL A Dawson, E Chow, P E Goss
British Journal of Cancer|February 1, 1985
Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced metabolismP E Goss, M Jarman, L J Griggs
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2006
Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are prematureT E Delea, J Karnon, P E Goss
Breast (Edinburgh, Scotland)|February 28, 2006
The extended adjuvant NCIC CTG MA.17 trials: initial and rerandomization studiesK I Pritchard, P E Goss, L Shepherd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodesM Crump, P E Goss, M Prince, et al.
Cancer|February 19, 2000
High dose chemotherapy and autologous blood stem cell support in women with breast carcinoma and isolated supraclavicular lymph node metastasesR Abraham, T Nagy, P E Goss, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Oncology (Williston Park, N.Y.)|December 12, 1997
Anastrozole: a new selective nonsteroidal aromatase inhibitorP E Goss, L M Tye
The Journal of Biological Chemistry|February 29, 2000
Characterization of a repressor element and a juxtaposed tissue-restricted activator element located on the distal neu gene promoterT C Suen, P E Goss
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Current perspectives on aromatase inhibitors in breast cancerP E Goss, K M Gwyn
The Journal of Biological Chemistry|October 26, 1999
Transcription of BRCA1 is dependent on the formation of a specific protein-DNA complex on the minimal BRCA1 Bi-directional promoterT C Suen, P E Goss
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Evolving perspectives in contralateral breast cancerL A Dawson, E Chow, P E Goss
British Journal of Cancer|February 1, 1985
Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced metabolismP E Goss, M Jarman, L J Griggs
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2006
Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are prematureT E Delea, J Karnon, P E Goss
Breast (Edinburgh, Scotland)|February 28, 2006
The extended adjuvant NCIC CTG MA.17 trials: initial and rerandomization studiesK I Pritchard, P E Goss, L Shepherd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodesM Crump, P E Goss, M Prince, et al.
Cancer|February 19, 2000
High dose chemotherapy and autologous blood stem cell support in women with breast carcinoma and isolated supraclavicular lymph node metastasesR Abraham, T Nagy, P E Goss, et al.
Pageof 8